Target intelligence / Profile preview

Corpus cavernosum penis (CC)

Target
CC
Molecular classification
Anatomical structure, Tissue
01

Overview

The corpus cavernosum is one of a pair of sponge-like regions of erectile tissue, which contain most of the blood in the penis during an erection (StatPearls, 2023). It consists of irregular blood-filled spaces called sinusoids, which are lined by endothelial cells and surrounded by smooth muscle and a fibroelastic extracellular matrix (Wikipedia, 2023). Physiologically, the corpus cavernosum facilitates penile tumescence through the relaxation of trabecular smooth muscle in response to nitric oxide, a process mediated by the secondary messenger cyclic guanosine monophosphate (cGMP) (PubMed, 2021). While not a single protein or receptor, it serves as the functional site for various pharmacological interventions, most notably phosphodiesterase type 5 (PDE5) inhibitors like sildenafil, which prevent the breakdown of cGMP to maintain blood flow (NIH, 2022). Pathological conditions associated with this tissue include erectile dysfunction, priapism (persistent and painful erection), and Peyronie's disease, which involves the development of fibrous scar tissue (Mayo Clinic, 2023). Therapeutic challenges include the risk of priapism, a medical emergency where blood becomes trapped in the cavernous spaces, potentially leading to permanent tissue damage (StatPearls, 2023).

Other names
Corpora cavernosaErectile tissueCorpus cavernosum
02

Mechanism of action

Pharmacological agents typically target enzymes (e.g., PDE5) or receptors (e.g., EP receptors) within the smooth muscle cells of the corpus cavernosum to increase cyclic guanosine monophosphate (cGMP) or cyclic adenosine monophosphate (cAMP) levels, leading to smooth muscle relaxation and increased blood inflow (NIH, 2022; PubMed, 2021).

03

Biological functions

Penile erectionSmooth muscle relaxationVasodilationBlood storageTumescence
04

Disease associations

Erectile dysfunctionPriapismPeyronie's diseaseCavernous fibrosis
05

Safety considerations

PriapismCavernous fibrosisHypotensionPenile painIschemic injury
06

Interacting drugs

Sildenafil

6 more in the full profile.

07

Biomarkers

Intracorporeal pressure (ICP)Penile blood flow velocityNocturnal penile tumescence (NPT)Peak systolic velocity (PSV)

Beyond the preview

Go deeper on Corpus cavernosum penis (CC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corpus cavernosum penis (CC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call